Literature DB >> 33396182

Geissospermiculatine, a New Alkaloid from Geissospermum reticulatum Bark.

Joanna J Sajkowska-Kozielewicz1, Paweł Kozielewicz2,3, Katerina Makarova1, Marcin Stocki4, Nicholas M Barnes3, Katarzyna Paradowska1.   

Abstract

A new alkaloid, geissospermiculatine was characterized in Geissospermum reticulatum A. H. Gentry bark (Apocynaceae). Here, following a simplified isolation protocol, the structure of the alkaloid was elucidated through GC-MS, LC-MS/MS, 1D, and 2D NMR (COSY, ROESY, HSQC, HMBC, 1H-15N HMBC). Cytotoxic properties were evaluated in vitro on malignant THP-1 cells, and the results demonstrated that the cytotoxicity of the alkaloid (30  μg/mL) was comparable with staurosporine (10  μM). Additionally, the toxicity was tested on zebrafish (Danio rerio) embryos in vivo by monitoring their development (0-72 h); toxicity was not evident at 30  μg/mL.

Entities:  

Keywords:  Apocynaceae; Danio rerio; Geissospermum reticulatum; NMR; alkaloids; cytotoxic effects

Mesh:

Substances:

Year:  2020        PMID: 33396182      PMCID: PMC7795935          DOI: 10.3390/molecules26010143

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  15 in total

1.  A search for natural bioactive compounds in Bolivia through a multidisciplinary approach. Part I. Evaluation of the antimalarial activity of plants used by the Chacobo Indians.

Authors:  V Muñoz; M Sauvain; G Bourdy; J Callapa; S Bergeron; I Rojas; J A Bravo; L Balderrama; B Ortiz; A Gimenez; E Deharo
Journal:  J Ethnopharmacol       Date:  2000-02       Impact factor: 4.360

2.  Geissospermum vellosii stembark: anticholinesterase activity and improvement of scopolamine-induced memory deficits.

Authors:  Josélia A Lima; Rodrigo Saar Costa; Rosangela A Epifânio; Newton G Castro; Mônica S Rocha; Angelo C Pinto
Journal:  Pharmacol Biochem Behav       Date:  2009-02-05       Impact factor: 3.533

3.  Amazonian plant crude extract screening for activity against multidrug-resistant bacteria.

Authors:  A F Correia; J F O Segovia; M C A Gonçalves; V L de Oliveira; D Silveira; J C T Carvalho; L I B Kanzaki
Journal:  Eur Rev Med Pharmacol Sci       Date:  2008 Nov-Dec       Impact factor: 3.507

4.  Antioxidant activity of ethanolic and aqueous extracts of Uncaria tomentosa (Willd.) DC.

Authors:  Radosław Pilarski; Henryk Zieliński; Danuta Ciesiołka; Krzysztof Gulewicz
Journal:  J Ethnopharmacol       Date:  2005-09-30       Impact factor: 4.360

5.  Indole alkaloids from Geissospermum reticulatum.

Authors:  M Reina; W Ruiz-Mesia; M López-Rodríguez; L Ruiz-Mesia; A González-Coloma; R Martínez-Díaz
Journal:  J Nat Prod       Date:  2012-05-02       Impact factor: 4.050

Review 6.  Progress of pharmacological studies on alkaloids from Apocynaceae.

Authors:  Lu Liu; Jian-Xin Cao; Yuan-Cheng Yao; Sheng-Ping Xu
Journal:  J Asian Nat Prod Res       Date:  2012-12-19       Impact factor: 1.569

7.  Evidence for a role of 5-HT(1A) receptor on antinociceptive action from Geissospermum vellosii.

Authors:  Juliana A T Werner; Sara M Oliveira; Daniel F Martins; Leidiane Mazzardo; Josiane de F G Dias; Ana L L Lordello; Obdúlio G Miguel; Luiz Fernando Royes; Juliano Ferreira; Adair R S Santos
Journal:  J Ethnopharmacol       Date:  2009-06-02       Impact factor: 4.360

8.  Synergistic and cytotoxic action of indole alkaloids produced from elicited cell cultures of Catharanthus roseus.

Authors:  Francisco Fernández-Pérez; Lorena Almagro; Maria A Pedreño; Laura V Gómez Ros
Journal:  Pharm Biol       Date:  2012-11-08       Impact factor: 3.503

9.  In vitro inhibition of human leukemia THP-1 cells by Origanum syriacum L. and Thymus vulgaris L. extracts.

Authors:  Basim M Ayesh; Abdalla A Abed; Doa'a M Faris
Journal:  BMC Res Notes       Date:  2014-09-07

10.  Antioxidant, Cytotoxic, and Antiproliferative Activities and Total Polyphenol Contents of the Extracts of Geissospermum reticulatum Bark.

Authors:  Joanna J Sajkowska-Kozielewicz; Paweł Kozielewicz; Nicholas M Barnes; Iwona Wawer; Katarzyna Paradowska
Journal:  Oxid Med Cell Longev       Date:  2016-06-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.